Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/10071275

Download in:

View as

General Info

PMID
10071275